Lila AI Designs CAR-T Therapy in Months, Outperforms Leading Treatment in Preclinical Tests
tw_killian · x · 2026-08-29
Biotech company Lila Sciences announced that its scientists used their AI platform to design a novel CAR-T cancer therapy in just months, which outperformed a leading therapy in preclinical testing.
- Core Technology: The platform trains a scientific reasoning model not only on published papers but also on hundreds of thousands of data points from in-house wetlab runs, including failed experiments.
- Track Record: Previously, the platform discovered ultra-stable mRNA sequences.
- Vision: The company aims to build "superintelligence" to accelerate the path from scientific idea to therapy.
Related event: Lila Sciences AI Platform Designs Superior CAR-T Therapy in Months(3 posts)→
More from Apps
- Open Nshipyard cleans Canada's messy civic data, exposing $15.1B phantom spend, with MCP tools for agents — RichardsonDx · 2026-10-16
- Ex-DeepMind Eng Lead's AI Calling Agent Fo Cut Hang-Up Rate from 80% to 20-30% — julianweisser · 2026-10-16
- Zero-latency lab-in-the-loop tests whether drug-discovery agents cheat via memorization — niloofar_mire · 2026-10-16
- fal launches Worlds for real-time creation and interaction with AI-generated worlds — Scobleizer · 2026-10-16
- Bland's new text agent Blandie shares memory with its voice AI for seamless call-to-SMS handoff — testingcatalog · 2026-10-16
- Google Search AI keeps getting better, but users want it as the primary experience — dreamwieber · 2026-10-16